ZenTrip 25 mg Disintegrating Oral Tablet
RxNorm 2540687
Concept Hierarchy & Relationship Mapping
RxNorm Concept Unique Identifier (RxCUI) 2540687 represents a standardized clinical drug concept used for cross-system interoperability. This concept aggregates multiple Atom IDs (AUIs), which are specific naming variations and synonyms used across pharmaceutical databases to ensure accurate medication mapping for: ZenTrip 25 mg Disintegrating Oral Tablet.
The following semantic concepts and normalized strings are associated with this clinical entity:
This clinical crossover tool is designed for healthcare professionals, pharmacists, and data analysts to safely compare substitute products and manage medication interoperability.
SBD
Semantic Branded Drug (SBD):
Meclizine hydrochloride 25 mg Disintegrating Oral Tablet [Zentrip]
(Atom ID: 12629523)
PSN
Prescribable Name (PSN):
ZenTrip 25 mg Disintegrating Oral Tablet
(Atom ID: 12629524)
SY
Synonym (SY):
Zentrip 25 mg Disintegrating Oral Tablet
(Atom ID: 12629525)
Patient Education
Meclizine
Meclizine is used to prevent and treat nausea, vomiting, and dizziness caused by motion sickness. It is most effective if taken before symptoms appear.
[Learn More]
* Please review the disclaimer below.